Ketamine Infusion Therapy Now Available in Carlsbad New Mexico
Klarisana has opened its first New Mexico center in Carlsbad. Now, residents of southeast New Mexico have access to ketamine infusion therapy for the treatment of depression, PTSD, anxiety, alcohol...(PRWeb September 14, 2018)Read the full story at https://www.prweb.com/releases/ketamine_infusion_therapy_now_available_in_carlsbad_new_mexico/prweb15748287.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - September 14, 2018 Category: Pharmaceuticals Source Type: news

NCLT allows Shivinder Mohan Singh to withdraw plea against elder brother Malvinder Singh
However, a counsel for Religare Enterprises, which was also a respondent in the case, said there were allegations against the company of siphoning off funds by the Singh brothers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 14, 2018 Category: Pharmaceuticals Source Type: news

DaVita Labs to open 150,000-square-foot DeLand campus, add 100+ jobs
DaVita Labs just expanded its operations in DeLand after opening a new 150,000-square-foot campus. The company broke ground on the facility in the city's Northwest Industrial Business Park in 2016 and will move into it by the end of this year. The facility will add more than 100 new jobs for the company, which has 450 employees in the area. “DaVita’s laboratory facility was the largest bui lding permit in DeLand’s history,” DeLand Mayor Bob Apgar said in a preparded statement. “More importantly,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: Ryan Lynch Source Type: news

Atrium Health waives virtual-care fees as Hurricane Florence nears landfall
Charlotte-based Atrium Health is offering free virtual care for its patients displaced by Hurricane Florence. Patients in the Carolinas who are experiencing minor injuries or illnesses, such as cold or flu-like symptoms, pinkeye or urinary tract infections can video chat with a medical provider at no cost to them. Atrium implemented free virtual care on Thursday for the duration of the storm. It is availa ble 24 hours a day. To receive free care, patients should log on and use the coupon code "FLORENCE"… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: Caroline Hudson Source Type: news

President of Oregon's second-biggest health insurer says midterms could reshape health care debate (Q & A)
Angela Dowling adds that state health plans are still coping with uncertainty from federal actions and hopes her organization can collaborate on any new policies. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: Brandon Sawyer Source Type: news

Portland agency receives $2.5M grant to expand mental health services to homeless youth
Outside In received a $2.5 million federal grant that will enable the Portland social service agency to triple the number of young adults it treats for mental health and substance use problems. Outside In was one of 16 organizations across the country to receive a grant from the Substance Abuse and Mental Health Services Administration to treat people with serious mental illness and emotion disorders who are experiencing homelessness. The funding will be spread out over five years, said Amanda… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Oregon bioscience incubator cruises to success in first five years
The state has realized a “remarkable” return — $706 million from OTRADI and OBI companies — on its investment of $1.25 million a year in the incubator. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

CDC: About One in Five U.S. Adults Have Chronic Pain
THURSDAY, Sept. 13, 2018 -- About 20.4 percent of U.S. adults have chronic pain and 8.0 percent have high-impact chronic pain, according to research published in the Sept. 14 issue of the U.S. Centers for Disease Control and Prevention's Morbidity... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

No Apparent Short-Term Cancer Risk From Recalled Valsartan
THURSDAY, Sept. 13, 2018 -- Users of valsartan contaminated with N-nitrosodimethylamine (NDMA) seem not to have increased cancer risk, according to a study published online Sept. 12 in The BMJ. Anton Potteg ård, Ph.D., from the University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Including Calorie Count on Menus Can Cut Calories Ordered
THURSDAY, Sept. 13, 2018 -- Including calorie count information on restaurant menus can result in a reduction in calories ordered, specifically in appetizers and entrees, according to a policy paper issued by the National Bureau of Economic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Experts Advise Against Universal DNA Sequencing of Newborns
THURSDAY, Sept. 13, 2018 -- Newborns should not undergo universal sequencing at birth, according to a report published in the July/August issue of The Hasting Center Report. Josephine Johnston, J.D., from The Hastings Center in Garrison, N.Y., and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Firearm Deaths Up Globally From 1990 to 2016
THURSDAY, Sept. 13, 2018 -- Firearm deaths increased globally between 1990 and 2016, according to a study published in the Aug. 28 issue of the Journal of the American Medical Association. Mohsen Naghavi, M.D., Ph.D., from University of Washington... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

FDA approves subcutaneous formulation of Actemra for use in active systemic juvenile idiopathic arthritis (sJIA), a rare form of juvenile arthritis
Roche announced today that the US Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra ® (tocilizumab) for the treatment of active systemic juvenile idiopathic arthritis (sJIA) in patients two years of age and older. (Source: Roche Investor Update)
Source: Roche Investor Update - September 13, 2018 Category: Pharmaceuticals Source Type: news

Healogics, Inc. Names Michael Fogarty as New Chief Operating Officer
JACKSONVILLE, Fla., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Healogics®, the nation's wound expert, today announced that it has appointed Michael Fogarty to serve as Chief Operating Officer. He will be replacing Greg Martin who will... Devices, Wound Care, Personnel Healogics, Wound Care Center (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Olympus Introduces EZ Shot 3 Plus 25 G EUS Needle with Enhanced Maneuverability for Uncompromised Access to Any Lesion, Consistent Performance to Potentially Reduce Procedural Costs and Procedure Time
Entire EZ Shot 3 Plus Line-Up Now Cleared for Fine Needle Biopsy CENTER VALLEY, Pa., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgic... Devices, Oncology, FDA, Product Launch Olympus Medical Systems, EZ Shot 3 Plus, EZ Shot, fine needle biopsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

City of Boston sues drugmakers over opioid epidemic
The City of Boston filed a lawsuit Thursday against several pharmaceutical companies that make opioid drugs, joining dozens of other cities and towns in Massachusetts — as well as Attorney General Maura Healey — in seeking damages over the opioid crisis. The city, along with the Boston Public Health Commission and the Boston Housing Authority, filed a complaint in Suffolk County Superior Court Thursday afternoon against Connecticut-based Purdue Pharma LP; i ts predecessor company, Purdue Frederick… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 13, 2018 Category: Biotechnology Authors: Jessica Bartlett Source Type: news

Mylan Adds to Cardiovascular Portfolio With Launch of First Generic of Brevibloc(R) Injection in Single-Dose Bags
Esmolol Hydrochloride in Sodium Chloride Injection is used to control heart rate HERTFORDSHIRE, England and PITTSBURGH, Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Global pharmaceutical company Mylan N.V. (NASDAQ : MYL ) today announced... Biopharmaceuticals, Generics, Product Launch Mylan, Esmolol, Brevibloc (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves CroFab(R) Product Improvements
Updated label describes extended shelf life and removal of mercury WEST CONSHOHOCKEN, Pa., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- BTG plc (LSE : BTG ) announced that the US Food & Drug Administration (FDA) has approved updating the... Biopharmaceuticals, FDA BTG, CroFab, Crotalidae Polyvalent Immune Fab, antivenom, pit viper (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

IFM Therapeutics, LLC Appoints John Leonard, M.D. to Board of Directors
Seasoned industry leader to provide expert counsel to help guide strategic growth of IFM Therapeutics, LLC BOSTON, Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- IFM Therapeutics, LLC (IFM), a privately held biopharmaceutical company focus... Biopharmaceuticals, Personnel IFM Therapeutics, innate immune system (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Abbott Declares 379th Consecutive Quarterly Dividend
(Source: Abbott.com)
Source: Abbott.com - September 13, 2018 Category: Pharmaceuticals Source Type: news

European Commission expands labelling for Janssen ’s INVOKANA® and VOKANAMET® to include positive data on cardiovascular outcomes
(Source: Johnson and Johnson)
Source: Johnson and Johnson - September 13, 2018 Category: Pharmaceuticals Source Type: news

Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
- Company achieves more than double the overall average industry score and maintains top industry scores in economic and social performance (Source: Abbott.com)
Source: Abbott.com - September 13, 2018 Category: Pharmaceuticals Source Type: news

From the Editor: Rising Up
Rather than complaining about the wind, pharma adjusts its sails (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 13, 2018 Category: Pharmaceuticals Source Type: news

Trends in Pharma Sales
Channels: CommercialImage: URL: http://1.eyeforpharma.com/LP=22033?extsource=efp_linkedin&utm_source=efp%20website&utm_campaign=4987&utm_content=Sales%20MMExclude from Homepage: No (Source: EyeForPharma)
Source: EyeForPharma - September 13, 2018 Category: Pharmaceuticals Authors: Izzy Gladstone Source Type: news

BI Joins Pharma Frenzy For Cancer-Killing Viruses With $244M Acquisition
With its purchase of ViraTherapeutics, German's Boehringer Ingelheim joins a large and growing list of Big Pharma companies investing in viruses that are engineered to seek out and destroy cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 13, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Source Type: news

13.09.18: Stefan Oelrich to join Bayer Board of Management and head Pharmaceuticals Division
Stefan Oelrich to join Bayer Board of Management and head Pharmaceuticals DivisionDieter Weinand leaving the company as of November 1, 2018 / Contract extensions for Board of Management members Liam Condon and Dr. Hartmut Klusikmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - September 13, 2018 Category: Pharmaceuticals Source Type: news

AngioDynamics expands oncology business with RadiaDyne acquisition
Medical device maker AngioDynamics is expanding its oncology business with the acquisition of RadiaDyne in Houston. RadiaDyne generates $6 million a year in sales designing patient dosage monitoring systems. The acquisition is expected to close at the end of September. Terms were not disclosed. The transaction comes as AngioDynamics consolidates and expands its oncology business at its Glens Falls, New York, m anufacturing complex. Oncology is the smallest, but fastest-growing of AngioDynamics… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: Robin K. Cooper Source Type: news

XACT Robotics Receives CE Mark for Its Robotics Navigation System for Percutaneous Procedures
Company closes $5 million in round C investment First clinical center of excellence using the XACT system launched at Hadassah Medical Center CAESAREA, Israel, Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- XACT Robotics, a pioneer in ... Devices, Regulatory, Venture Capital XACT Robotics, XACT image guided, robotic navigation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Hanger resumes trading on NYSE after long comeback
After years of tumult, Hanger Inc. is back in the good graces of regulators. The Austin-based company that operates a network of about 800 clinics for people who use orthotic and prosthetic devices said Wednesday that its shares were once again trading on the New York Stock Exchange under the ticker "HNGR." It marked the completion of an arduous comeback, as Hanger executi ves spent nearly four years refiling financial disclosures. Hanger "underwent a fundamental transformation of our corporate… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: Will Anderson Source Type: news

FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
TARRYTOWN, N.Y., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ : REGN ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Appli... Biopharmaceuticals, Ophthalmology Regeneron Pharmaceuticals, EYLEA, aflibercept, diabetic retinopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration
FREMONT, Calif., Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Ardelyx, Inc. (Nasdaq : ARDX ), today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting U.S. marketing authoriz... Biopharmaceuticals, Gastroenterology Ardelyx, tenapanor, IBS-C, irritable bowel syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

AbbVie Announces Patient-Reported Outcomes Data from Three Pivotal Phase 3 Studies of Risankizumab, Showing Significant Improvements in Health-Related Quality of Life for Patients with Psoriasis
Pooled analyses from ultIMMa-1 and ultIMMa-2 studies showed significantly more patients treated with risankizumab were symptom-free (psoriasis symptom scale [PSS] score of 0) compared to placebo and STELARA® (ustekinumab) after 16 weeks and at one year... Biopharmaceuticals, Dermatology AbbVie, Risankizumab, psoriasis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Targovax Strengthens Management Team With the Appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO
OSLO, Norway, Sept. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, ... Biopharmaceuticals, Oncology, Personnel Targovax (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2018 Category: Pharmaceuticals Source Type: news

Fred's May Sell More Pharmacies Amid Turnaround
Fred ’s continues to “evaluate strategic opportunities” for its remaining pharmacy business after announcing the sale of prescription files from 185 pharmacies to Walgreens. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 13, 2018 Category: Pharmaceuticals Authors: Bruce Japsen, Contributor Tags: NASDAQ:WBA NYSE:CVS NYSE:RAD NASDAQ:FRED Source Type: news

Photos: Apple unveils new Watch with FDA approval and biggest, most expensive iPhone yet
Apple Inc. executives took to the stage at the company's Cupertino headquarters on Wednesday to unveil a lineup of bigger, pricier iPhones and a revamped Apple Watch with new health and medical features and a first-of-its-kind approval from federal drug regulators. The company unveiled a new Apple Watch with an electrical heart rate sensor and new software to detect irregular heart rhythms. The device is the first "over the counter" electrocardiography (ECG) device that has received U.S. Food… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: SVBJ staff Source Type: news

Can A Cancer Drug Originated In China Be A Success In The U.S.?
Fruquintinib may not be the best test case for bringing a homegrown China medicine to the U.S. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 13, 2018 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: ETR:BAYN NYSE:RHHBY Source Type: news

CDC: Infant Mortality Rate Varies Greatly Among States
THURSDAY, Sept. 13, 2018 -- Infant mortality rates in the United States vary substantially by state, according to a QuickStats report published in the Aug. 24 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

AHA: Resistant Hypertension Diagnosis, Tx Guidelines Updated
THURSDAY, Sept. 13, 2018 -- A correct diagnosis of resistant hypertension is necessary to avoid overmedicating, according to a scientific statement from the American Heart Association published online Sept. 13 in Hypertension. Robert M. Carey, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Pharmacovigilance Needed for Rheumatology Patients
THURSDAY, Sept. 13, 2018 -- Recommendations have been developed for pharmacovigilance in rheumatology, emphasizing the need for continued monitoring of new drugs, according to a position statement issued by the American College of Rheumatology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

New Risk Score Promising for Predicting MI, Death
THURSDAY, Sept. 13, 2018 -- A score based on the results of three laboratory tests has higher sensitivity and specificity than cardiac troponin alone for stratifying patients presenting with suspected acute coronary syndrome, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Pediatricians Have a Role in Encouraging Play Among Children
THURSDAY, Sept. 13, 2018 -- Pediatricians should encourage parents to ensure their children play, according to a clinical report published in the September issue of Pediatrics. Michael Yogman, M.D., from Harvard University and Mount Auburn Hospital... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Prurigo Nodularis More Likely in African-Americans
THURSDAY, Sept. 13, 2018 -- African-American patients are more likely to have prurigo nodularis (PN), which is associated with systemic, cardiovascular, and psychiatric comorbidities, according to a study recently published in the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Physicians Need Training for Mass Casualty Incidents
THURSDAY, Sept. 13, 2018 -- Proper training and post-incident steps can help lessen the secondary trauma health professionals experience providing care during mass casualty incidents (MCIs), according to an article published in the American Medical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Gains in Insurance Coverage Seen for Lesbian, Gay, Bisexual Adults
THURSDAY, Sept. 13, 2018 -- Lesbian, gay, and bisexual (LGB) adults report continued problems affording care despite coverage gains offered by the Affordable Care Act, according to a study published in the August issue of Health Affairs. Kevin H.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Worse Health Status With Shorter Telomere Length in COPD
THURSDAY, Sept. 13, 2018 -- Patients with chronic obstructive pulmonary disease (COPD) with shorter telomere length have worse health status, according to a study published in the August issue of CHEST. Minhee Jin, from the University of British... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Risks Posed by Spreading Oil and Gas Wastewater on Roads
THURSDAY, Sept. 13, 2018 -- Spreading oil and gas (O&G) wastewaters on roads may pose human and environmental risks, according to a study recently published in Environmental Science& Technology. Travis L. Tasker, from Pennsylvania State... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 13, 2018 Category: Pharmaceuticals Source Type: news

Health Care Heroes award winner: Dr. Allison Freeman, Allegheny Health Network
Dr. Allison Freeman is a 2018 Health Care Heroes award winner in the health care provider - individual category. Here's her story: To say that Dr. Allison Freeman has changed her mind about the treatment of food allergies would be a major understatement. “The last thing I did before I left Canada for the U.S. was help write the infant feeding guidelines that were designed to keep children from getting these allergies,” s he said. “Almost everything we wrote was wrong. Now we’ve rewritten… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: Richard Cerilli Source Type: news

(Photos): Apple unveils new Watch with FDA approval and biggest, most expensive iPhone yet
Apple Inc. executives took to the stage at the company's Cupertino headquarters on Wednesday to unveil a lineup of bigger, pricier iPhones and a revamped Apple Watch with new health and medical features and a first-of-its-kind approval from federal drug regulators. The company unveiled a new Apple Watch with an electrical heart rate sensor and new software to detect irregular heart rhythms. The device is the first "over the counter" electrocardiography (ECG) device that has received U.S. Food… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: SVBJ staff Source Type: news

Jimmy Buffett's Margaritaville to collaborate on medical marijuana brand – Coral Reefer
Instead of wasting away again in Margaritaville, Surterra Wellness has partnered with musician Jimmy Buffett's holding company on a new medical marijuana brand. The Margaritaville Holdings LLC team joined with the Ocilla, Georgia-based medical marijuana company, under Surterra Holdings Inc., to create Coral Reefer LLC. The venture will develop medical and therapeutic medical marijuana products, with a launch planned for Florida in spring 2019. “Final ly, ‘the time has come’, as the Walrus… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 13, 2018 Category: Pharmaceuticals Authors: Ryan Lynch Source Type: news

America's Most Dangerous Dog Breeds [Infographic]
Over the past 13 years, one dog breed in particular in the U.S. has been responsible for the most fatal attacks on humans. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 13, 2018 Category: Pharmaceuticals Authors: Niall McCarthy, Contributor Source Type: news